Prevention of Left Atrial Appendage Device-Related Thrombosis: Is Reduced-Dose Direct Oral Anticoagulation the Way Forward?
- PMID: 34656491
- DOI: 10.1016/j.jcin.2021.08.004
Prevention of Left Atrial Appendage Device-Related Thrombosis: Is Reduced-Dose Direct Oral Anticoagulation the Way Forward?
Keywords: device-related thrombosis; direct oral anticoagulation; left atrial appendage; left atrial appendage closure.
Conflict of interest statement
Funding Support and Author Disclosures Dr Nielsen-Kudsk holds a research grant from the Novo Nordisk Research Foundation (NNF17OC0024868, NNF17OC0029510); and is an investigator and a proctor for Abbott and Boston Scientific.
Comment on
-
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion.JACC Cardiovasc Interv. 2021 Nov 8;14(21):2353-2364. doi: 10.1016/j.jcin.2021.07.031. Epub 2021 Oct 13. JACC Cardiovasc Interv. 2021. PMID: 34656496
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
